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Abstract. 
 
Integrin activation is a multifaceted phenom-
enon leading to increased affinity and avidity for matrix 
ligands. To investigate whether cytokines produced 
during stromal infiltration of carcinoma cells activate 
nonfunctional epithelial integrins, a cellular system of 
human thyroid clones derived from normal glands 
(HTU-5) and papillary carcinomas (HTU-34) was em-
 
ployed. In HTU-5 cells, 
 
a
 
v
 
b
 
3 integrin was diffused all 
over the membrane, disconnected from the cytoskele-
ton, and unable to mediate adhesion. Conversely, in 
HTU-34 cells, 
 
a
 
v
 
b
 
3 was clustered at focal contacts 
(FCs) and mediated firm attachment and spreading. 
 
a
 
v
 
b
 
3 recruitment at FCs and ligand-binding activity, es-
sentially identical to those of HTU-34, occurred in 
HTU-5 cells upon treatment with hepatocyte growth 
factor/scatter factor (HGF/SF). The HTU-34 clone se-
creted HGF/SF and its receptor was constitutively ty-
rosine phosphorylated suggesting an autocrine loop re-
sponsible for 
 
a
 
v
 
b
 
3 activated state. Antibody-mediated 
inhibition of HGF/SF function in HTU-34 cells dis-
rupted 
 
a
 
v
 
b
 
3 enrichment at FCs and impaired adhesion. 
Accordingly, activation of 
 
a
 
v
 
b
 
3 in normal cells was 
produced by HTU-34 conditioned medium on the basis 
of its content of HGF/SF. These results provide the first 
example of a growth factor–driven integrin activation 
mechanism in normal epithelial cells and uncover the 
importance of cytokine-based autocrine loops for the 
physiological control of integrin activation.
Key words: integrins • thyroid • hepatocyte growth 
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A
 
dhesion
 
 to neighboring cells and the extracellular
matrix (ECM)
 
1
 
 plays a crucial role in different bio-
logical phenomena, including cell motility and tu-
mor invasion (Juliano and Varner, 1993; Chapman, 1997),
differentiation (Adams and Watt, 1993; Lin and Bissell,
1993; Gumbiner, 1996), and survival (Frisch and Francis,
1994). The malignant behavior of carcinoma cells is not
simply characterized by alteration or loss of growth con-
trol, a feature shared with benign neoplasms, but also by
the ability to weaken tissue constraints and invade foreign
districts, where cancer cells may migrate, proliferate, and
survive. This xenophilic tendency is fostered by coopera-
tion among ECM molecules, proteases, growth factors
(GFs), and the adhesion receptors expressed on the sur-
face of the invading cells, which together provide signals
controlling the organization of the cytoskeleton (Clark
and Brugge, 1995; Yamada and Miyamoto, 1995; Brooks
et al., 1996; Wei et al., 1996).
Physiological interactions between normal epithelial
cells and the underlying basal lamina, as well as recogni-
tion of matrix components by carcinoma cells during stro-
mal infiltration are mediated by the integrin family of ad-
hesion receptors, a class of transmembrane noncovalently
associated glycoprotein heterodimers composed of one 
 
a
 
and one 
 
b
 
 chain (Hynes, 1992; Sonnenberg, 1993). Con-
ceivably, migration of epithelial neoplastic cells within
stromal tissues involves changes in the expression, topog-
raphy, cytoskeletal association, and signaling properties of
the integrin repertoire. In fact, many in vivo and
 
 
 
in vitro
studies have reported surface modifications of integrin
levels, or even neo-expression of some integrins, in carci-
noma versus normal cells (Plantefaber and Hynes, 1989;
Zutter et al., 1995; Serini et al., 1996; for a comprehensive
review see Ben-Ze’ev, 1997). Such modifications might be
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proteinase-2; SFM, serum-free medium; VN, vitronectin.
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driven either by the ECM itself (Langhofer et al., 1993;
Rabinovitz and Mercurio, 1996), by GFs secreted by stro-
mal cells and stimulating the invasive neoplastic elements
in a paracrine fashion (Klemke et al., 1994; Doerr and
Jones, 1996), or even by cytokines synthesized de novo by
carcinoma cells and acting back on the tumor mass via an
autocrine circuit (Aasland et al., 1988; Bachrach et al.,
1988; Mizukami et al., 1991).
Cellular attachment to immobilized ECM ligands com-
monly results in cytoskeletal reorganization and clustering
of integrins at discrete adhesive sites known as focal con-
tacts (FCs). In these specialized structures, an array of
submembranous proteins ranging from structural mole-
cules to regulatory enzymes forms a multimolecular com-
plex linking the actin microfilament network with integrins
and, hence, with the ECM (Burridge and Chrzanowska-
Wodnicka, 1996). The formation of FCs triggers signal cas-
cades that act in concert with GF-activated transduction
pathways and can alter gene expression (Clark and
Brugge, 1995). Under given conditions, intracellular sig-
nals that originate at FCs or at downstream targets result
in modulation of the affinity and/or avidity of certain inte-
grins for extracellular ligands, a process termed activation
or inside-out signaling (Hynes, 1992).
Our goal was to investigate how variations in integrin
composition and GF receptor activation correlate with
changes in cell adhesion in carcinoma versus normal ele-
ments. We assumed that the tuning of the integrin adhe-
sive machinery occurring when tumor cells invade sur-
rounding tissues might include not only changes in
quantity but also changes in quality such as conversion of
integrins from a dormant, nonadhesive state into an active
one endowed with high adhesive capabilities. Specifically,
we postulated that such conversion could be induced by
one or more GFs acting within the neoplastic environ-
ment. The cellular model used in our experiments was a
panel of human thyroid clonal strains corresponding to
normal and malignant in vivo cell populations. These
clones can form epithelial colonies and, when cultured in
three-dimensional gels, develop aggregates whose biologi-
cal functions, differentiation parameters, and morphologi-
cal architecture are strictly related to the in vivo counter-
part (Curcio et al., 1994; Perrella et al., 1997; De Filippi, R.,
P.C. Marchisio, G. Serini, and L. Trusolino, manuscript in
preparation). Such a feature allows exhaustive compari-
sons between normal and carcinoma cells and is usually
limited or compromised in established cell lines, where re-
lationship studies of normal versus transformed pheno-
types appear to be extremely difficult.
In this report, we provide evidence that the 
 
a
 
v
 
b
 
3 inte-
grin is expressed by normal cells in a latent state character-
ized by its inability to form cytoskeletal connections and to
promote cell adhesion to ECM ligands. In contrast, 
 
a
 
v
 
b
 
3
is highly enriched at FCs of carcinoma cells and mediates
tight adhesion. We also demonstrate that the multifunc-
tional cytokine hepatocyte growth factor/scatter factor
(HGF/SF), but not other serum GFs, is an autocrine factor
for carcinoma cells and show that the signaling pathway
stimulated by HGF/SF, when elicited in normal cells, can
fully recapitulate the adhesive pattern of neoplastic ele-
ments. Indeed, no connections have been ever studied be-
tween a specific GF and activation of the adhesive capabil-
ities of an integrin in normal epithelial cells under
physiological conditions. Here we unravel such a func-
tional interplay and underscore the importance of auto-
crine production of GFs for the integrin-dependent inva-
sive behavior of carcinoma cells and, possibly, for the
activation state of integrins in general.
 
Materials and Methods
 
Cell Cultures
 
Clonal strains from human normal thyroid (HTU-5) and papillary carci-
noma (HTU-34) were obtained and cultured as previously described
(Curcio et al., 1994; Perrella et al., 1997). In brief, tissue samples from
pathological specimens of different patients were freed from adherent
connective tissue, cut into small pieces, washed in Ca
 
2
 
1
 
- and Mg
 
2
 
1
 
-free
HBSS, and enzymatically digested with a solution consisting of 20 U/ml
collagenase (CLSPA; Worthington Biochemical Corp., Freehold, NJ),
0.75 mg/ml trypsin (1:300; GIBCO BRL, Gaithersburg, MD), and 2%
heat-inactivated dialyzed chicken serum (GIBCO BRL), in Ca
 
2
 
1
 
- and
Mg
 
2
 
1
 
-free HBSS. Cell suspensions were collected after a 2 h digestion and
seeded onto 100-mm plastic tissue culture dishes (Falcon; Becton Dickin-
son, Lincoln Park, NJ). Culture medium was a modified F-12 further var-
ied to contain 0.48 mM MgCl
 
2
 
, 3 mM KCl, 5% Fetal Calf Serum (GIBCO
BRL), 1 mg/ml Na-insulin (Elanco, Indianapolis, IN), 5 
 
m
 
g/ml bovine
transferrin (GIBCO BRL), 0.01 mM hydrocortisone, 2 ng/ml selenous
acid, 3 pg/ml triiodothyronine (all from Sigma Chemical Co., St. Louis,
MO), 75 
 
m
 
g/ml bovine hypothalamus extracts and 5 
 
m
 
g/ml bovine pitu-
itary extracts (Pel Freez Biologicals, Rogers, AR). The purity of both
strains was assessed by examining the expression of thyroid-specific mo-
lecular markers (thyroglobulin, thyroperoxidase, TTF-1, and PAX-8) and
by evaluating thyrotropin-dependent c-AMP production and thymidine
incorporation. This in vitro profile was found to correlate with the degree
of differentiation of the starting specimen and with the pathological diag-
nosis (Perrella et al., 1997). Throughout the experiments, only cells from
the 2nd to the 5th passage were used.
 
Antibodies
 
The integrin-specific mAbs used in this study (with the investigators who
provided them) were as follows: MAR4 against 
 
b
 
1 and MAR6 against 
 
a
 
6
(from Sylvie Ménard, Istituto Nazionale Tumori, Milano, Italy; Bottini et
al., 1993); F2 against 
 
a
 
3 (from Luciano Zardi, Istituto Scientifico per lo
Studio e la Cura dei Tumori, Genova, Italy); L230 against 
 
a
 
v (from Paola
Defilippi, Dipartimento di Genetica, Biologia e Chimica Medica, Univer-
sity of Torino, Italy); AA3 against 
 
b
 
4 (from Vito Quaranta, Scripps Re-
search Institute, La Jolla, CA); VIPL-2 against 
 
b
 
3 (from Walter Knapp,
Institüt für Immunologie der Universität, Vienna, Austria); IA9 against
 
b
 
5 (from Martin Hemler and Renata Pasqualini, Dana-Farber Cancer In-
stitute, Boston, MA). Other mAbs against integrin subunits were com-
mercially obtained: Gi9 against 
 
a
 
2 and SAM-1 against 
 
a
 
5 (Immunotech,
Marseille, France); a rabbit polyclonal antiserum against 
 
b
 
3 and the func-
tion-blocking mAb LM609 against the integrin complex 
 
a
 
v
 
b
 
3 (Chemicon
International Inc., Temecula, CA). The inhibitory mAb AIIB2 against 
 
b
 
1
was provided by Caroline H. Damsky (Department of Stomatology, Uni-
versity of California at San Francisco, CA). Rabbit polyclonal antisera
against 
 
b
 
1 and 
 
a
 
v were, respectively, from Ivan de Curtis (DIBIT, Istituto
Scientifico San Raffaele, Milano, Italy) and Guido Tarone (Dipartimento
di Genetica, Biologia e Chimica Medica, University of Torino, Italy).
mAb VIN11.5 against vinculin was from Sigma Chemical Co. The C-28
rabbit antiserum against human HGF/SF receptor, used in immunoprecip-
itation experiments, was purchased from Santa Cruz Biotechnology
(Santa Cruz, CA); the mAb DQ-13 against human HGF/SF receptor, used
in Western blotting analyses, and the 4G10 anti-phosphotyrosine mAb
were from Upstate Biotechnology Inc. (Lake Placid, NY). 1W53, a neu-
tralizing sheep antiserum directed against human HGF/SF, was produced
in the laboratory of Ermanno Gherardi (Imperial Cancer Research Fund,
Cambridge University Medical School, UK) and kindly supplied by Paolo
Amati and Sergio Anastasi (Dipartimento di Biotecnologie Cellulari ed
Ematologia, Università “La Sapienza”, Rome, Italy). The neutralizing ac-
tivity was titrated in scatter assays on MDCK cells after HGF/SF stimula-
tion and found to be optimal at a 1:80 dilution. 
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Cytokines
 
HGF/SF and TGF
 
b
 
1 were purchased respectively from R & D Systems
Inc. (Minneapolis, MN; Van der Voort et al., 1997), and Boehringer Mann-
heim GmbH (Mannheim, Germany). EGF was kindly donated by Laura
Beguinot (DIBIT, Milano, Italy). Insulin and insulin-like growth factor
were a generous gift of Franco Folli (Divisione Universitaria di Medicina
Interna, Istituto Scientifico San Raffaele, Milano, Italy).
 
Immunoprecipitation and Western Blotting
 
Immunoprecipitations were carried out on surface-biotinylated cells as
previously described (Rabino et al., 1994). In brief, confluent monolayers
were washed three times at 4
 
8
 
C with Hank’s balanced salt biotinylation
buffer (HBB), pH 7.4, consisting of 1.3 mM CaCl
 
2
 
, 0.4 mM MgSO
 
4
 
, 5 mM
KCl, 138 mM NaCl, 5.6 mM 
 
d
 
-glucose, and 25 mM Hepes, pH 7.4. Sulfo-
succinimido biotin (Pierce Chemical Co., Rockford, IL) was made 0.5 mg/
ml in HBB and applied to the cells for 20 min at 4
 
8
 
C. The biotin solution
was then removed and replaced with fresh biotin solution for another 20
min. The reaction was stopped by incubating four times at 4
 
8
 
C with Mini-
mal Essential Medium containing Hank’s balanced salts, 0.6% BSA, 20
mM Hepes, pH 7.4. After three washes in cold HBB, cells were lysed for
30 min at 4
 
8
 
C in a buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl,
0.1% SDS, 1% Triton X-100, 0.5% sodium-deoxycholate, 5 mM EGTA,
50 mM NaF, and 5 mM MgCl
 
2
 
, supplemented with various phosphatase
and protease inhibitors (leupeptin, pepstatin, aprotinin, PMSF, soybean
trypsin inhibitor, and sodium-orthovanadate). Extracts were centrifuged
at 15,000 rpm for 30 min at 4
 
8
 
C, and supernatant protein content was nor-
malized with the BCA Protein Assay Reagent Kit (Pierce Chemical Co.).
Cell lysates were precleared onto protein A–Sepharose CL-4B (Pharma-
cia Biotech Sverige, Uppsala, Sweden) and rotated 2 h at 4
 
8
 
C with differ-
ent mAbs. Immunocomplexes were collected with affinity-purified rabbit
anti–mouse IgG (Pierce Chemical Co.) coupled to protein A–Sepharose.
After several washes with lysis buffer, the final pellets were eluted in boil-
ing Laemmli buffer and proteins were electrophoresed on 8% SDS-
PAGE. Samples were transferred onto Immobilon-P™ filters (Millipore
Corp., Bradford, MA), probed with peroxidase-conjugated streptavidin,
and visualized on Kodak X-OMAT AR films (Rochester, NY) by the En-
hanced Chemiluminescence System (Amersham Life Sciences, Little
Chalfont, UK). In biotinylation experiments of 
 
b
 
1 integrins, cells were
previously treated with 100 
 
m
 
g/ml trypsin in PBS twice for 20 min at 4
 
8
 
C,
followed by inactivation with complete medium (Boll et al., 1991).
 
Adhesion Assay
 
Cell adhesion was performed according to Grano et al. (1994), with minor
modifications. In brief, 96-well microtiter plates (polystyrene, nontissue
culture treated; Nunc Inc., Naperville, IL) were coated with increasing
concentrations of vitronectin (VN; Sigma Chemical Co.), fibrinogen
(Sigma Chemical Co.), and osteopontin (from Cecilia M. Giachelli and
Marta Scatena, Department of Pathology, University of Washington, Se-
attle, WA) in PBS, pH 7.4. In other assays, standard concentrations of 10
 
m
 
g/ml laminin (Sigma Chemical Co) and fibronectin (FN; from Paola De-
filippi, University of Torino) were used. Proteins were allowed to bind
overnight at 4
 
8
 
C before the wells were rinsed and blocked for 2 h at 37
 
8
 
C
with 3% heat-denatured BSA (RIA grade; Sigma Chemical Co.) in PBS,
pH 7.4. Cells were harvested and washed twice with serum-free medium
(SFM). To allow surface reexposure of integrin receptors, cells were incu-
bated on a rotating platform for 1 h at 37
 
8
 
C in SFM containing 0.1% BSA,
and then added to the wells at a concentration of 50,000 cells/0.1 ml of the
same medium. After a 3-h incubation at 37
 
8
 
C, wells were gently washed
twice in PBS. Adherent cells were fixed in 11% glutaraldehyde in PBS,
rinsed in distilled water, and stained with 0.1% crystal violet, 20% metha-
nol for 15 min. Cell numbers were obtained by counting all cells in four
grids using a phase-contrast light microscope fitted with a 32 grid eyepiece
at a total magnification of 100
 
3
 
 (Doerr and Jones, 1996). All data pre-
sented are the means 
 
6
 
 SD of duplicate wells from three or more experi-
ments. Nonspecific cell adhesion as measured on BSA-coated wells has
been subtracted.
In adhesion inhibition experiments, cells were plated onto the substrata
in the presence of serial dilutions of the function-blocking mAbs LM609
or AIIB2. Alternatively, HTU-34 cells were treated for 2 d with 250 
 
m
 
g/ml
suramin or with 1W53 antibody against HGF/SF and then processed for
the adhesion assay; suramin or the inhibitory antibody was kept in all
steps of the assays. Preimmune sera were used in control experiments.
 
In some assays, adherent HTU-5 cells were serum-starved for 36 h, har-
vested, and plated onto VN in SFM-0.1% BSA in the presence of single
GFs or HTU-34–conditioned medium. In the case of TGF
 
b
 
1 treatment,
before harvesting cells were pretreated with TGF
 
b
 
1 for 24 h. Alterna-
tively, HTU-34–conditioned medium was preincubated with the 1W53 an-
tibody against HGF/SF or with sheep normal IgGs (Sigma Chemical Co.)
for 30 min and then applied to HTU-5 cells (see Results).
 
Indirect Immunofluorescence Microscopy
 
Cells from confluent monolayers were plated onto 24-well plates (Costar
Corp.) containing 1.4-cm
 
2
 
 glass coverslips. After 4 d in culture, cells were
fixed for 5 min at room temperature in a freshly prepared solution of 3%
formaldehyde (from paraformaldehyde) in PBS, pH 7.6, containing 2%
sucrose. In some cases, cells were permeabilized by soaking coverslips for
3 min at room temperature in Hepes-Triton X-100 buffer (20 mM Hepes,
pH 7.4, 300 mM sucrose, 50 mM NaCl, 3 mM MgCl
 
2
 
, and 0.5% Triton X-100;
Fey et al., 1983; Rabinovitz and Mercurio, 1997). Indirect immunofluores-
cence was performed as previously reported (De Luca et al., 1990;
Marchisio et al., 1991). In brief, after a 15-min saturation with PBS-2%
BSA at 37
 
8
 
C, the primary antibodies were layered onto cells and incu-
bated in a moist chamber for 30 min. After rinsing in PBS-0.2% BSA, cov-
erslips were incubated with the appropriate rhodamine-tagged secondary
antibody (DAKOPATTS, Copenhagen, Denmark) for 30 min at 37
 
8
 
C in
the presence of 2 
 
m
 
g/ml of fluorescein-labeled phalloidin (Sigma Chemi-
cal Co.). Coverslips were mounted in Mowiol 4-88 (Hoechst AG, Frank-
furt, Germany) and observed in a photomicroscope (Axiophot; Zeiss,
Jena, Germany) equipped with epifluorescence lamp and planapochro-
matic oil immersion lenses. Fluorescence images were recorded on Kodak
T-Max 400 photographic films exposed at 1,000 ISO and developed in
T-Max Developer for 10 min at 20
 
8
 
C.
In some experiments, coverslip-attached HTU-5 cells were serum-starved
for 36 h and then treated with HGF/SF or with HTU-34–conditioned me-
dium (see Results). In other cases, HTU-34 cells were treated for 2 d with
1W53 antibody against HGF/SF or with sheep preimmune sera (Sigma
Chemical Co.) and then processed for immunofluorescence.
 
FACS
 
®
 
 Analysis
 
FACS
 
®
 
 analysis was performed according to Peruzzi et al. (1996), with mi-
nor modifications. In brief, HTU-5 and HTU-34 cells were harvested with
1 mM EDTA in PBS, washed in ice-cold PBS-2%BSA, 5 mM NaN
 
3
 
, and
incubated with mAb VIPL-2 against the 
 
b
 
3 integrin subunit (10 
 
m
 
g/ml) for
40 min at 4
 
8
 
C. Cells were then rinsed and treated with fluorescein-tagged
rabbit anti–mouse IgG (DAKOPATTS) for 30 min. All incubations were
performed in PBS-0.2%BSA, 5 mM NaN
 
3
 
 at 4
 
8
 
C. Fluorescence was mea-
sured using a FACScan
 
®
 
 flow cytometer (Becton Dickinson, Mountain
View, CA) set to count 10,000 cells per sample. The data were collected
and analyzed with a MacIntosh Power PC computer equipped with
CELLQuest research software (Becton Dickinson). Positive fluorescence
was determined on a four log scale and expressed as channel number
mean intensity fluorescence (MIF). Background fluorescence was deter-
mined on each cell population using fluorescein-tagged rabbit anti–mouse
IgGs alone.
 
Northern Blotting
 
Total RNA was isolated from confluent monolayers of HTU-5 and HTU-
34 cells by the acid guanidium method (Chomczynski and Sacchi, 1987).
Northern blots were performed with 30 
 
m
 
g total RNA per lane. Ethidium
bromide at a concentration of 0.2 
 
m
 
g/ml was added before electrophoresis
in 1% agarose gels containing formaldehyde to verify the integrity of the
RNA by short-wavelength UV detection and to monitor the equivalence
of loading before and after transfer to GeneScreen Plus filters (Du Pont
NEN, Boston, MA). A full-length HGF/SF cDNA probe (from Gianni
Gaudino, Dipartimento di Scienze e Tecnologie Avanzate, University of
Alessandria, Italy) and a probe for the housekeeper gene glyceraldehyde-3
phosphate dehydrogenase (GAPDH, from Fanny Sciacca, DIBIT, Mi-
lano, Italy) were labeled with random priming (Rediprime DNA labeling
system; Amersham Life Sciences) and [
 
32
 
P]dCTP (3,000 Ci/mmol; Amer-
sham Life Sciences). Membranes were pretreated and hybridized in 50%
formamide (Merck, Darmstad, Germany), 10% dextran sulfate (Sigma
Chemical Co.), 1% SDS, and 50 
 
m
 
g/ml salmon sperm DNA, at 42
 
8
 
C. Blots
were washed twice with 2
 
3
 
 SSC at room temperature for 10 min, then
twice in 2
 
3
 
 SSC 1% SDS at 65
 
8
 
C for 30 min, and finally once in 2
 
3
 
 SSC at 
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room temperature for 5 min, followed by exposure to autoradiography for
48 h at –80
 
8
 
C with intensifying screens.
 
Results
 
Thyroid Clonal Strains Express 
 
a
 
v
 
b
 
3, 
 
a
 
v
 
b
 
1, and
 
a
 
3
 
b
 
1 Integrins
 
To characterize the surface adhesive repertoire of normal
(HTU-5) and malignant (HTU-34) thyroid cells, a battery
of integrin-specific mAbs was used in immunoprecipita-
tion experiments on membrane biotinylated cell monolay-
ers. The 
 
a
 
v mAb L230 immunoprecipitated three bands of
150, 130, and 90 kD in both the normal and carcinoma
strains (Fig. 1 
 
A
 
). The 150/90-kD doublet was also brought
down by the 
 
b
 
3-specific mAb VIPL2 (Fig. 1 B) but not by
the b5 mAb IA9 (not shown). Based on band intensities,
the avb3 integrin appeared to be more expressed in the
HTU-34 clone. The higher surface exposure of avb3 in
carcinoma cells was confirmed by FACS® analysis on
HTU-5 (Fig. 1 C) and HTU-34 (Fig. 1 D) cells.
The faint 130-kD band coprecipitating with the av sub-
unit could be interpreted as an av-associated b1 chain. To
test the nature of this band, anti-av immunoprecipitates
from equal amounts of HTU-5 and HTU-34 cell extracts
were transferred onto Immobilon-P™ membranes and
probed with a b1 polyclonal antiserum: in fact, a specific
130-kD band corresponding to the b1 subunit was de-
tected in both clones (Fig. 1 E). Under standard condi-
tions, surface biotinylation of b1 integrins was extremely
difficult, possibly because the accessibility of this integrin
to biotin was compromised by the adhesive meshwork of
basement membrane components (Gottardi and Caplan,
1992). To overcome this problem we employed a mild
trypsinization protocol that enhances the ability of biotin
to interact with ventral proteins (Boll et al., 1991). By this
procedure, immunoprecipitation of HTU-5 and HTU-34
cell lysates with the b1 mAb MAR4 yielded two bands of
similar intensity at 150 and 130 kD, representing one or
more b1-associated a chains and the b1 subunit (Fig. 1 F),
respectively. To further define which a subunits, besides
av, could heterodimerize with the b1 chain, mAbs against
a2, a3, a5, and a6 were used in immunoprecipitation as-
says on biotinylated normal and malignant cells. Only the
a3-mAb F2 was able to precipitate two bands of 150 and
130 kD comigrating with the a3 and b1 integrin subunits
(Fig. 1 G). These same mAbs were also used in immuno-
fluorescence experiments; consistently with the immuno-
precipitation analysis, among the a subunits tested only a3
and av were immunoreactive (not shown).
Taken together, these data demonstrate that the inte-
grins expressed at the surface of normal and malignant
thyroid clones include the avb1, avb3, and a3b1 het-
erodimers. The b1 chain is thus shared by the a3 and av
subunits.
The Integrin avb3 Is Clustered at Focal
Contacts and Mediates Adhesion in Malignant but Not 
in Normal Thyroid Cells
The only modification in integrin repertoire observed in
malignant versus normal thyroid cells was the higher sur-
face expression of the avb3 heterodimer in HTU-34 cells
(Fig. 1, A–D). To evaluate the subcellular distribution of
avb3 in normal and carcinoma clones, cells were plated
onto glass coverslips, cultured for several days, and then
subjected to immunofluorescence. Under these condi-
tions, cell adhesion occurs because of endogenous produc-
tion of matrix molecules. Immunofluorescence experi-
ments on fixed, nonpermeabilized cells were in accordance
with the immunoprecipitation data: a fine grainy pattern
of immunoreactivity was much stronger in HTU-34 (Fig. 2
B) than in HTU-5 cells (Fig. 2 A). Interestingly, treatment
of fixed cells with permeabilization buffer (0.5% Triton
X-100), which extracts freely diffusing molecules yet pre-
serves actin cytoskeletal connections (Fey et al., 1983;
Figure 1. Characterization of the sur-
face integrin repertoire in HTU-5 and
HTU-34 thyroid clonal strains. Conflu-
ent cells were surface biotinylated and
detergent lysates were immunoprecipi-
tated with the indicated mAbs to dif-
ferent integrin subunits as described in
Materials and Methods. The eluates
were then analyzed by SDS-PAGE un-
der nonreducing conditions. To dem-
onstrate association of the b1 subunit
with the av chain, anti-av immunopre-
cipitates were Western blotted and then decorated with a b1 polyclonal
antiserum (E). Cell surface expression of the b3 subunit was also as-
sessed by FACS® analysis (C and D). Washed, unfixed HTU-5 (C) and
HTU-34 (D) cells were stained for indirect immunofluorescence and
flow cytometry analysis as described in Materials and Methods. Each
profile was generated from analyzing 10,000 cells. Relative values of
MIF were derived from gated computerized histogram analysis and ex-
pressed as log arbitrary units. Nonspecific fluorescence was measured
using the secondary fluorescein-tagged rabbit anti–mouse IgGs alone
(shaded diagrams) and found to have a MIF ,7. Specific b3 fluores-
cence (black diagrams) corresponded to a MIF of 38.7 in HTU-5 cells
and 238.44 in HTU-34 cells.Trusolino et al. Integrin Activation in Epithelial Cells 1149
Rabinovitz and Mercurio, 1997), completely removed b3
immunoreactivity in HTU-5 cells (Fig. 2, C and D) and se-
lectively concentrated the b3 fluorescent signal of HTU-34
cells at the endings of microfilament bundles in sites com-
patible with FCs (Fig. 2, E and F). The same result was ob-
tained when Triton X-100 permeabilization was per-
formed before fixation (not shown). Thus, recruitment of
the avb3 heterodimer to microfilament-associated adhe-
sion sites occurs only in malignant but not in normal thy-
roid cells.
To induce ligand-mediated clustering of avb3 in HTU-5
normal cells, subconfluent cultures were detached and
plated in serum-free conditions onto a plastic substratum
coated with a concentration range (2.5 to 25 mg/ml) of VN
(Fig. 3 A), fibrinogen (Fig. 3 B), and osteopontin (Fig. 3
C). Surprisingly, HTU-5 cells could not attach and spread. In
contrast, HTU-34 cells rapidly adhered and firmly spread;
indeed, cells attached proportionally to the amount of sub-
stratum and were detectable even at very low doses of ma-
trix ligands (Fig. 3, A–C). HTU-34 cell attachment and
spreading on VN was progressively impaired by adding in-
creasing concentrations of the avb3 inhibitory mAb
LM609 but not by the b1 function-blocking mAb AIIB2
(Fig. 3 D). Moreover, in HTU-34 cells plated on VN and
processed for immunofluorescence after fixation and per-
meabilization, the only integrin receptor clustered at na-
scent FC, strictly colocalizing with vinculin (Fig. 3 F), was
avb3 (Fig. 3 E). Conversely, b1 integrins were almost un-
detectable on the cell surface (Fig. 3 G). Thus, adhesion of
HTU-34 cells to VN was specifically mediated by avb3.
When HTU-5 were plated onto FN, a ligand for both
avb3 and avb1, cells could attach and spread. In this case
as well, avb3 was not involved in the adhesive phenome-
non: only the b1 inhibitory mAb efficiently blocked adhe-
sion whereas mAb LM609 did not display any significant
effect (Fig. 4 A). Conversely, b1 and b3 integrins were
equally responsible for adhesion to FN in HTU-34 cells:
function-blocking mAbs against either integrins could par-
tially impair adhesion when added individually, and al-
most totally when added together (Fig. 4 A). Immunofluo-
rescence experiments showed that HTU-5 cells, when
plated on FN, organized b1 integrins at adhesive struc-
tures (Fig. 4 B), whereas avb3 was almost undetectable
(Fig. 4 C). On the contrary, in HTU-34 plated on FN both
b1 and b3 integrins were highly enriched at focal adhe-
sions; double immunostaining for b1 and b3 revealed colo-
calization of the two integrin subunits within the same FCs
(Fig. 4, D and E).
In summary, these results indicate that adhesion to VN,
fibrinogen, and osteopontin occurs only in malignant
HTU-34 cells and that, in this strain, adhesion is specifi-
cally driven by avb3. Adhesion to FN occurs in both
strains and is governed by the selective activity of b1 inte-
grins in HTU-5 cells and by the cooperative action of b1
and b3 integrins in HTU-34 cells.
We hypothesized that the discrepancy in adhesion effi-
ciency between HTU-5 and HTU-34 cells was due to the
different expression levels of the avb3 integrin receptor.
To test this hypothesis, HTU-5 were treated with TGF-b1,
known to induce upregulation of avb3 synthesis and sur-
face exposure (Ignotz et al., 1989). Indeed, TGF-b1 in-
creased the expression of avb3 but could not induce avb3
recruitment at cytoskeleton-associated FCs nor enhance
HTU-5 cell adhesion to VN (not shown). These findings
suggest that avb3 upregulation is not sufficient per se to
trigger cluster formation and firm adhesion in HTU-5
cells. Thus, we can reasonably rule out the possibility that
the different adhesive capabilities of carcinoma versus
normal cells are simply related to the higher surface expo-
sure of avb3 in the HTU-34 clone.
A Carcinoma-specific Autocrine Loop Sustains
avb3-mediated Adhesion
Since the assembly of integrin adhesion complexes re-
quires serum soluble factors in some cell types (Hotchin
and Hall, 1995), and on the basis of mounting evidence
that integrins and GF receptors share common signaling
pathways (Clark and Brugge, 1995), we assumed that sig-
nals derived from a GF receptor could be responsible for
maintaining avb3 in a constitutively proadhesive activated
state.
In a preliminary test of this possibility we plated HTU-34
cells on VN after preincubation with suramin, a drug that
Figure 2. b3 integrin is clustered at FCs only in HTU-34 cells. In
A and B, HTU-5 (A) and HTU-34 (B) cells were fixed and di-
rectly immunostained with a b3 mAb. In C and F, HTU-5 (C and
D) and HTU-34 (E and F) cells were fixed, permeabilized with a
Triton X-100 buffer that removes most of the soluble proteins but
not cytoskeleton-associated molecules, and then stained by a
double immunofluorescence protocol using the b3 mAb followed
by a rhodamine-conjugated rabbit anti–mouse IgG (C and E) and
by fluorescein-tagged phalloidin (D and F). In nonpermeabilized
cells, b3 displayed a fine grainy pattern (A and B) and the signal
was much stronger in the HTU-34 strain (B). After permeabiliza-
tion, b3 immunoreactivity was completely abrogated in HTU-5
cells (C and D) and selectively enriched at FCs in the HTU-34
clone (E and F). Bar, 10 mm.The Journal of Cell Biology, Volume 142, 1998 1150
blocks any cytokine–receptor interactions (La Rocca et al.,
1990; Adams et al., 1991; Ferracini et al., 1995; Zumkeller
and Schofield, 1995). Indeed, HTU-34 cells completely
lost their adhesion potential (Fig. 5 A) suggesting that
avb3 adhesive properties were controlled by a soluble fac-
tor interacting with a receptor. To test this hypothesis we
challenged HTU-5 cells with SFM conditioned by the
HTU-34 clone and found that cells acquired de novo adhe-
sion to VN (Fig. 5 A). When HTU-34–conditioned me-
dium was applied to HTU-5 cells previously plated onto
glass coverslips, thus adhering to endogenous ECM mole-
cules, avb3 recruitment at FCs was observed (Fig. 5, B and
C). It was deduced that a soluble factor produced by ma-
lignant cells, but not by normal cells, controlled avb3-
mediated adhesion by acting on a receptor shared by the
two cell types.
HGF/SF Promotes avb3-mediated Adhesion
The multifunctional cytokine HGF/SF was selected as the
object of closer investigation for several reasons: (a) the
HGF/SF receptor c-Met is constitutively activated in thy-
roid carcinomas (Di Renzo et al., 1992, 1995); (b) HGF/SF
autocrine release has been reported to represent a selec-
tive advantage for tumor progression (Tsao et al., 1993;
Ferracini et al., 1995); (c) the morphogenic responses to
HGF/SF are critically dependent on cell adhesion (Matsu-
moto et al., 1995); and (d) finally, HGF/SF has been shown
to enhance adhesion of B cells and lymphoma cells, thus
suggesting its involvement in integrin activation mecha-
nisms (Van der Voort et al., 1997; Weimar et al., 1997).
Indeed, HGF/SF clearly promoted attachment and
spreading of HTU-5 cells on VN in a dose-dependent
manner (Fig. 6 A). HGF/SF-induced adhesion was specifi-
cally inhibited by mAb LM609 against avb3 (Fig. 6 B). In
agreement with these findings, HTU-34 adhesion on VN
was impaired by a functional antibody to HGF/SF (Fig. 6
B). Moreover, this antibody, but not normal sheep serum,
blocked the ability of HTU-34–conditioned medium to in-
duce adhesion of HTU-5 cells (Fig. 6 B). The proadhesive
effect of HGF/SF was specific insofar that TGF-b1 could
not enhance HTU-5 cell adhesion to VN (not shown) nor
could EGF, insulin, and insulin-like growth factor-1 (Fig. 6
B). It has already been demonstrated that receptors for
EGF, insulin, and insulin-like growth factor-1 are present
in thyroid cells (Dumont et al., 1991); however, to ascer-
tain that also HTU-5 cells express these receptors, we per-
formed Western blot experiments on total cell lysates after
GF stimulation and verified the induction of multiple ty-
rosine phosphorylated bands (not shown).
When HTU-5 cells were plated on FN in the presence of
HGF/SF, adhesion was markedly enhanced (Fig. 6 C).
Blockade of the b1 integrin receptors by means of mAb
AIIB2 under basal conditions abolished adhesion, that
was partially restored by adding HGF/SF (Fig. 6 C). Adhe-
sion levels after inhibition of avb3 by mAb LM609 in the
presence of HGF/SF were roughly comparable to those
obtained under basal conditions (Fig. 6 C). When both b1
and b3 integrins were blocked by their respective inhibi-
tory mAbs, adhesion was totally abolished and stimulation
with HGF/SF was ineffective (Fig. 6 C). Taken together,
these results indicate that HGF/SF enhances adhesion effi-
ciency of HTU-5 cells on FN by promoting avb3-mediated
attachment and spreading. Hence, avb3 activation signifi-
cantly increases the level of basal adhesion mediated by b1
integrins.
As a control, HTU-5 and HTU-34 cells were plated on
laminin (Fig. 6 D). Both clones adhered at comparable lev-
els and adhesion was blocked by the b1 mAb AIIB2, act-
Figure 3. avb3 integrin displays ligand-binding activity and is re-
cruited to newly forming adhesive structures only in HTU-34
cells. (A–D) Adhesion assays onto avb3-specific ECM molecules.
(A–C) Cells from HTU-5 (closed symbols) and HTU-34 (open
symbols) cultures were detached, resuspended in SFM, and then
plated onto microtiter wells coated with increasing amounts of
VN (A), fibrinogen (B), and osteopontin (C). After allowing cells
to attach, the extent of cell adhesion was quantitated as described
in Materials and Methods. (D) Adhesion inhibition assay.
HTU-34 cells were plated onto 10 mg/ml VN alone (2) or in the
presence of increasing concentrations of function-blocking mAbs
to avb3 (LM 609) or to b1 (AII B2). (E–G) Immunofluores-
cence. HTU-34 cells were detached, resuspended in SFM, and
plated for 2 h onto glass coverslips coated with VN. Cells were
then fixed, permeabilized, and processed for double immunofluo-
rescence using a rabbit polyclonal antiserum against b3 (E) and
an mAb against vinculin (F). An mAb against b1 was also used
(G) in single immunofluorescence experiments. In adhering
HTU-34 cells, b3 and vinculin, but not b1, were recruited to ma-
turing FCs. Bar, 7 mm.Trusolino et al. Integrin Activation in Epithelial Cells 1151
ing conceivably on the a3b1 heterodimer. Addition of
HGF/SF did not modify cell attachment and spreading. Thus,
the effect of HGF/SF on cell adhesion is specifically medi-
ated by avb3 and is independent of the substratum recog-
nized by this integrin, being exerted on both VN and FN.
In immunofluorescence experiments on HTU-5 cells ad-
hering onto endogenous ECM molecules, HGF/SF trig-
gered clustering of avb3 at FCs (Fig. 7, A and B). Consis-
tent with this observation, treatment of HTU-34 cells with
the inhibitory antibody to HGF/SF resulted in a clear-cut
decrease in the focal immunostaining for avb3 (Fig. 7, C
and D), but no modifications in the topography of the b1
subunit (Fig. 7, E and F) or vinculin (Fig. 7, G and H) were
observed. avb3 expression levels in HTU-5 clones did not
increase upon stimulation with HGF/SF, nor did they de-
crease after antibody-mediated neutralization of HGF/SF
activity in the HTU-34 cultures (not shown).
To determine whether HTU-5 and HTU-34 cells ex-
pressed the HGF/SF receptor c-Met and to verify whether
the receptor was constitutively activated in HTU-34 cells
because of a chronic autocrine loop, cell lysates were sub-
jected to immunoprecipitation with the C-28 human Met
polyclonal antibody. Anti-Met immunoprecipitates were
then split into two equal fractions, Western blotted, and
decorated with the anti-Met mAb DQ-13 (Fig. 8 A) or the
phosphotyrosine mAb 4G10 (Fig. 8 B). In both cell lines,
the 145-kD mature form of the c-Met b subunit was clearly
detected (Fig. 8 A). The c-Met b subunit was phosphory-
lated on tyrosine residues in HTU-34 cell extracts, but not
in unstimulated HTU-5 cell lysates. When HTU-5 cells
were treated with conditioned medium from the HTU-34
Figure 4.( A ) Adhesion and adhesion inhibition assay of HTU-5
(hatched bars) and HTU-34 (open bars) cells onto FN. Cells were
plated onto 10 mg/ml FN alone (2) or in the presence of mAbs
LM609 (10 mg/ml) and/or AIIB2 (1:10 dilution). (B–E) Immuno-
fluorescence. When HTU-5 cells were allowed to adhere to FN
(B and C), the b1 chain (B) but not the b3 subunit (C) was clus-
tered at nascent FCs. In HTU-34 cells plated on FN, both inte-
grins were recruited to adhesion sites (D and E). Double-immu-
nofluorescence analysis using an mAb to b1 (D) and a rabbit
polyclonal antiserum to b3 (E) showed that both subunits were
clustered within the same focal adhesions. Bar, 10 mm.
Figure 5. A soluble factor produced by HTU-34 cells is responsi-
ble for avb3 ligand-binding activity and recruitment to FCs. (A)
Adhesion assay. Treatment of HTU-34 cells (open bars) with
suramin (Sur) markedly reduced adhesion to VN. Conversely,
conditioned medium from the HTU-34 clone (Cond.) triggered
adhesion of HTU-5 cells (hatched bars). (B and C) Immunofluo-
rescence. HTU-5 cells were either left untreated (B) or stimu-
lated for 1 h with conditioned medium from the HTU-34 clone
(C); cells were then fixed, permeabilized, and processed for im-
munofluorescence using an mAb against the b3 integrin subunit.
Bar, 10 mm.The Journal of Cell Biology, Volume 142, 1998 1152
clone or with purified HGF/SF, specific tyrosine phosphor-
ylation of the c-Met b subunit was detected (Fig. 8 B).
The presence of HGF/SF in the supernatant of HTU-34
cells was tested by assaying its scatter activity in MDCK
epithelial cells after serial dilutions in standard medium.
At a 1:10 dilution, conditioned supernatant was able to
dissociate epithelial colonies, although it did not achieve
the maximal effect observed with recombinant HGF/SF
(not shown).
Finally, Northern blot analysis identified a specific 6-kb
transcript, equivalent in size to the principal HGF/SF
mRNA species (Nakamura et al., 1989), only in HTU-34
cells (Fig. 8 C). We believe that these results unequivo-
cally substantiate the existence of a natural autocrine loop
for HGF/SF in HTU-34 cells.
Discussion
A New Physiological Mechanism for Integrin Activation 
in Epithelia
Normal epithelial cells require integrin-mediated adhesion
to ECM molecules of the basement membrane for GF
control of the cell cycle (Assoian, 1997). In this paper we
report that the opposite phenomenon also occurs, i.e., that
integrin-dependent cellular adhesion requires GFs to take
place. Namely, we report that the HGF/SF-dependent sig-
nal transduction pathway can induce ligand-binding activ-
ity in functionally inactive avb3 integrins.
The activation of integrins is characterized by conforma-
tional changes in their extracellular domain, reorganiza-
tion of their cytoplasmic connections, and clustering of
heterodimers within the plane of the plasma membrane,
which together augment integrin affinity and avidity for
ligands and stabilize adhesion (Du et al., 1991; Diamond
and Springer, 1994; Li et al., 1995; Yednock et al., 1995).
The molecular mechanisms responsible for physiological
activation are still unclear (Lasky, 1997). Moreover, al-
though this phenomenon has been extensively studied in
platelets and leukocytes, little information is available for
cells that are part of compact tissues and adhere to base-
ment membranes, such as epithelial cells. Recently, Pelle-
tier et al. (1996) reported that avb3 activation in a mela-
noma cell line involves a cation binding site that regulates
integrin conformation. Even more recently, Fenczik et al.
(1997) identified CD98, a type II membrane glycoprotein
involved in early T cell activation and expressed in many
adherent cell lines, as a factor responsible for b1 integrin
activation. The mechanisms that regulate clustering of in-
tegrins and their recruitment at FCs also are poorly under-
stood. Experiments with antibody- and ligand-coated
beads have shown that clustering of integrins depends
upon binding to multivalent matrix molecules and that FC
assembly requires both integrin–ligand interaction and ag-
gregation of integrins (Miyamoto et al., 1995).
Figure 6. HGF/SF selectively
activates the adhesive po-
tential of avb3 integrin in
HTU-5 cells. (A) HGF/SF
promotes  avb3-mediated
adhesion to VN in a dose-
dependent manner. Cells
from HTU-5 cultures were
detached, resuspended in
SFM containing increasing
amounts of HGF/SF, and
then plated onto VN. (B)
The effect of HGF/SF on
avb3-mediated adhesion is
specific and in malignant
cells it results from an auto-
crine loop. HGF/SF was the
only stimulus able to trigger
adhesion of HTU-5 cells
(hatched bars) to VN. Treat-
ment of HTU-34 cells (open
bars) with a blocking poly-
clonal antiserum to HGF/SF
(anti-HGF) markedly re-
duced adhesion. HGF/SF-
induced adhesion in HTU-5
cells was inhibited by mAb
LM609 to the b3 subunit
(HGF1LM609) and by treating HTU-34–conditioned medium with the inhibitory antiserum against HGF/SF (Cond 1 anti-HGF). In
contrast, addition of preimmune sheep IgGs to HTU-34 cells (P-I) did not modify their adhesive properties. Similarly, treatment of
HTU-5 cells with HTU-34–conditioned medium in the presence of preimmune IgGs (Cond 1 P-I) had no effect on the ability of condi-
tioned medium to trigger cell adhesion. (C) HGF/SF increases adhesion efficiency of HTU-5 cells on FN via the enhancement of avb3
ligand-binding ability (see Results). (D) HGF/SF does not modify the adhesive function of laminin-binding integrins. Attachment of
both HTU-5 (hatched bars) and HTU-34 (open bars) cells to laminin was inhibited by the b1 function-blocking mAb AIIB2, but was not
modulated by HGF/SF treatment.Trusolino et al. Integrin Activation in Epithelial Cells 1153
Data presented in this study indicate that both integrin
aggregation and triggering of efficient ligand-binding ca-
pability in adherent normal cells require the presence of
GFs; in particular, HGF/SF displays the unique ability to
recruit avb3 to FCs and to stimulate avb3-mediated adhe-
sion. Since no changes in avb3 expression levels can be
observed upon HGF/SF treatment, we interpret HGF/SF-
induced adhesion as a conversion of the integrin func-
tional state from inactive to active, with consequent acqui-
sition of ligand-binding ability. To our knowledge, these
findings are the first example of a GF-driven integrin acti-
vation mechanism in adherent cells. Moreover, because
we use an epithelial cell model presumably mirroring the
adhesive environment of solid normal tissues and tumors,
we elucidate one of the mechanisms that coordinate inte-
grin and GF receptor function in normal and transformed
epithelia under conditions that parallel several in vivo situ-
ations.
How can HGF/SF elicit clustering and activation of
avb3? One possibility is that the activated GF receptor di-
rectly acts on the b3 cytoplasmic domain and that this, in
turn, induces a conformational change in the integrin re-
sulting in ligand binding. Integrin–ligand interaction
would then trigger avb3 clustering at FCs. However, we
could never show any obvious biochemical modification of
the b3 integrin tail like HGF/SF-induced tyrosine phos-
Figure 7. HGF/SF promotes clustering of b3 integrin at FCs (A
and B). HTU-5 cells were either left untreated (A) or incubated
for 1 h with 50 ng/ml purified HGF/SF (B); cells were then fixed,
permeabilized, and processed for immunofluorescence using an
mAb against b3. Antibody-mediated inhibition of HGF/SF func-
tion in HTU-34 cells selectively induces b3 disconnection from
FCs (C-H). HTU-34 cells were incubated for 2 d with either a
preimmune sheep serum (C, E, and G) or with a function-block-
ing sheep antiserum to HGF/SF (D, F, and H); cells were then
fixed, permeabilized, and processed for immunofluorescence us-
ing mAbs against b3 (C and D), b1 (E and F) and vinculin (G and
H). HGF/SF inhibition resulted in strong reduction of the b3
staining at FCs, with partial peripheral redistribution. No modifi-
cations of the immunoreactivity for b1 and vinculin could be ob-
served upon HGF/SF blockade. Bar, 10 mm.
Figure 8. Biochemical evidence of HGF/SF autocrine production
by the HTU-34 clone. HTU-5 cells were either left untreated or
incubated for 10 min with conditioned medium from the HTU-34
clone (cm HTU-5) or with 50 ng purified HGF/SF (HGF/SF
HTU-5). Unstimulated and stimulated HTU-5 cells, together
with untreated HTU-34 cells, were extracted and immunoprecipi-
tated with a human c-Met polyclonal antibody. The eluates were
then split into two equal fractions, Western blotted, and deco-
rated with mAbs to c-Met (A, anti-Met) or to phosphotyrosine (B,
anti-PY). The c-Met receptor b chain (Met145b) appeared to be
constitutively tyrosine-phosphorylated in the HTU-34 strain.
Specific tyrosine-phosphorylation of the Met protein could be in-
duced in HTU-5 cells by treatment with HTU-34–conditioned
medium or with HGF/SF. The HGF/SF transcript is specifically
expressed in HTU-34, but not in HTU-5, cells (C). 30 mg of total
RNA from HTU-5 and HTU-34 cells were separated by electro-
phoresis, transferred to nylon filters, and hybridized to 32P-
labeled probes specific for HGF/SF and for the housekeeper
gene GAPDH.The Journal of Cell Biology, Volume 142, 1998 1154
phorylation nor formation of a complex between the acti-
vated HGF/SF receptor and the avb3 integrin.
A second possibility is that HGF/SF activates the avb3
integrin in an indirect manner, e.g., by modifying a range
of intermediate effectors. Good candidates for this role
would include CD98 analogues (see above) or b3-endo-
nexin, a cytosolic protein that selectively binds the b3
cytodomain and modulates its affinity state (Shattil et al.,
1995; Kashiwagi et al., 1997).
In a third scenario, HGF/SF might affect one or more of
the submembranous components of the FCs. Because
most of these components, as well as integrin cytoplasmic
tails, have been shown to interact in vitro with each other,
this could lead to avb3 recruitment via the formation of
multiple cross-links (Turner and Burridge, 1991; Sastry
and Horwitz, 1993; Gilmore and Burridge, 1996). Accord-
ing to this hypothesis, clustered integrins would form a
high density, high valency complex with increased avidity
for ligands, thus leading to stabilization of integrin–ligand
interactions, firm adhesion, and spreading. Interestingly,
HGF/SF is known to induce tyrosine phosphorylation of
pp125FAK (Matsumoto et al., 1994), a cytosolic tyrosine ki-
nase enriched at FCs and able to phosphorylate other FC
components including paxillin and tensin (Schaller and
Parsons, 1994).
Implications for Tumor Invasion
All the morphological and functional features evoked by
HGF/SF in normal thyroid cells spontaneously occur in
carcinoma cells because of a natural HGF/SF autocrine
loop. Inhibition of this loop markedly reduces avb3 en-
richment at FCs and binding to immobilized ligands.
Hence, whereas HGF/SF treatment of normal cells reca-
pitulates the overall adhesive phenotype of carcinoma
cells, neutralization of HGF/SF activity in neoplastic ele-
ments can per se revert avb3 from a functional to a latent
state.
Although in different ways, both HGF/SF and avb3 in-
tegrin contribute to the malignant behavior of neoplastic
cells. HGF/SF is responsible for invasive growth of tu-
mors, a complex phenomenon resulting from the combina-
tion of proliferation, motility, ECM degradation, and cell
survival. Specifically, HGF/SF impairs the compaction of
polarized epithelia by disrupting the architecture of adher-
ens junctions and inducing the appearance of a fibroblas-
toid phenotype endowed with motile properties (Stoker et
al., 1987; Gherardi et al., 1989; Weidner et al., 1990, 1991;
Igawa et al., 1991; Kan et al., 1991; Matsumoto et al., 1991;
Naldini et al., 1991; Rubin et al., 1991). This scatter activity
is corroborated by HGF/SF ability to promote the synthe-
sis of ECM-degrading proteases, including urokinase plas-
minogen activator (uPA; Pepper et al., 1992; Boccaccio et al.,
1994; Jeffers et al., 1996) and matrix metalloproteinase-2
(MMP-2; Zeigler et al., 1996), thus enhancing cell inva-
siveness into stromal compartments. Finally, HGF/SF can
protect epithelial cells from anoikis, a form of pro-
grammed cell death occurring when adherent cells are de-
tached from their physiological matrix substrata (Frisch
and Francis, 1994; Longati et al., 1996; Amicone et al.,
1997). In fact, when carcinoma cells infiltrate connective
tissues and blood vessels before systemic dissemination,
they lose contact with their basal lamina and, to escape
anoikis, must recognize previously unknown ECM compo-
nents. It is tempting to speculate that the survival message
conveyed by HGF/SF resides, at least partially, in its abil-
ity to activate the function of the avb3 integrin, thus sup-
plying an adhesive information that may confer resistance
to anoikis. From this viewpoint, the ability of HGF/SF to
activate avb3 in carcinoma cells results in a double selec-
tive advantage: (a) it provides a functional receptor for
stromal invasion and (b) it protects tumors from massive
apoptosis.
Similarly to HGF/SF, avb3 is directly involved in inva-
sive and antiapoptotic phenomena. This integrin is upreg-
ulated in melanoma clones endowed with high metastatic
potential (Nip et al., 1995) and is physically associated
with MMP-2 at the invasive front of infiltrating cells, in or-
der to concentrate matrix degradation at adhesive sites
and facilitate directed cellular motility (Brooks et al.,
1996). Interestingly, avb3 is de novo expressed on the sur-
face of endothelial cells during intratumoral formation of
blood vessels (Brooks et al., 1994) and regulates the sur-
vival of newly sprouting blood vessels (Stromblad et al.,
1996); likewise, HGF/SF displays powerful angiogenic ac-
tivity (Bussolino et al., 1992). Altogether, data support the
concept of a functional synergy between HGF/SF-depen-
dent biological pathways and avb3-mediated adhesion
processes in several neoplastic phenomena including ma-
trix degradation, invasion, cell survival, and tumor neoan-
giogenesis.
It is worth noting that in many cell lines (the HTU-5 thy-
roid clone being a prominent exception) avb3 appears to
be spontaneously clustered at FCs. In some cells, the basal
activation state of the integrin may be intrinsically high,
or perhaps more likely, maintained by autocrine produc-
tion of HGF/SF. Accordingly, many examples of natural
autocrine cells for HGF/SF have been described (Adams et
al., 1991; Rong et al., 1992, 1993; Tsao et al., 1993; Grano et
al., 1994; Ferracini et al., 1995; Woolf et al., 1995; Maier
et al., 1996; Anastasi et al., 1997). An alternative hypothe-
sis stems from the observation that in a variety of cell lines
simple cellular adhesion is sufficient to elicit ligand-inde-
pendent activation of the HGF/SF receptor (Wang et al.,
1996). In this case, recruitment of avb3 at FCs would be
the consequence of adhesion-dependent constitutive acti-
vation of the kinase receptor rather than a cellular re-
sponse to chronic autocrine stimulation by the growth fac-
tor ligand. Notably, activation of the HGF/SF receptor by
cell attachment occurs in many tumor cells, but not in pri-
mary or clonal cultures of normal cells (Wang et al., 1996).
In conclusion, we propose here a novel regulatory mech-
anism that epithelial cells use for integrin activation and in
the ensuing integrin–ligand interaction phenomena. To
our knowledge, this is the first report describing the spe-
cific modulation operated by a GF on the adhesive state
and aggregation rate of an individual integrin in epithelial
cells. Moreover, because avb3 activation is obtained upon
stimulation with a GF that is physiologically present
within the interstitial milieu of compact tissues and can be
pathologically overexpressed in cancer, this mechanism
can have strong in vivo implications for the adhesive be-
havior of parenchymal cells and for their interactions with
stromal components. In addition, our results highlight theTrusolino et al. Integrin Activation in Epithelial Cells 1155
importance of GF autocrine production in the regulation
of integrin function during tumor invasion.
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